交易 Cerevel Therapeutics Holdings, Inc. - CERE CFD
加入收藏夹- 概括
- 历史数据
- 活动
- 收入报表
- 资产负债表
- 现金流
- 所有权
交易条件
价差 | 0.11 | ||||||||
多头隔夜费
Long position overnight fee
前往平台 | -0.030779% | ||||||||
空头隔夜费
Short position overnight fee
前往平台 | -0.013666% | ||||||||
隔夜费时间 | 22:00 (UTC) | ||||||||
最小交易量 | 1 | ||||||||
货币 | USD | ||||||||
保证金 | 20% | ||||||||
上市交易所 | United States of America | ||||||||
交易费 | 0% |
*Information provided by Capital.com
- Last Week
- Last Month
- Last Year
- Last two Years
- Max
- Daily
- Weekly
- Monthly
Date | 平倉 | Change | Change (%) | 開倉 | High | Low |
---|---|---|---|---|---|---|
Jun 29, 2022 | 26.95 | 1.81 | 7.20% | 25.14 | 27.30 | 25.14 |
Jun 28, 2022 | 26.94 | -0.93 | -3.34% | 27.87 | 29.13 | 26.80 |
Jun 27, 2022 | 28.99 | 0.89 | 3.17% | 28.10 | 29.70 | 27.49 |
Jun 24, 2022 | 28.08 | -0.17 | -0.60% | 28.25 | 29.09 | 27.63 |
Jun 23, 2022 | 28.54 | 3.28 | 12.98% | 25.26 | 28.60 | 25.26 |
Jun 22, 2022 | 26.05 | 1.34 | 5.42% | 24.71 | 26.24 | 24.71 |
Jun 21, 2022 | 25.15 | -0.32 | -1.26% | 25.47 | 25.47 | 24.03 |
Jun 17, 2022 | 23.86 | 0.20 | 0.85% | 23.66 | 24.42 | 23.16 |
Jun 16, 2022 | 22.85 | -1.18 | -4.91% | 24.03 | 24.03 | 22.07 |
Jun 15, 2022 | 24.53 | 0.31 | 1.28% | 24.22 | 24.87 | 23.33 |
Jun 14, 2022 | 24.22 | 0.64 | 2.71% | 23.58 | 25.12 | 23.54 |
Jun 13, 2022 | 23.87 | -0.71 | -2.89% | 24.58 | 24.67 | 23.20 |
Jun 10, 2022 | 25.82 | -0.27 | -1.03% | 26.09 | 27.04 | 25.60 |
Jun 9, 2022 | 27.99 | 0.51 | 1.86% | 27.48 | 28.92 | 27.48 |
Jun 8, 2022 | 28.49 | 1.30 | 4.78% | 27.19 | 29.41 | 27.19 |
Jun 7, 2022 | 28.72 | 3.24 | 12.72% | 25.48 | 28.84 | 25.48 |
Jun 6, 2022 | 25.86 | -1.88 | -6.78% | 27.74 | 28.32 | 25.13 |
Jun 3, 2022 | 27.78 | 1.02 | 3.81% | 26.76 | 28.51 | 26.76 |
Jun 2, 2022 | 26.98 | 1.06 | 4.09% | 25.92 | 27.80 | 25.30 |
Jun 1, 2022 | 26.37 | 0.40 | 1.54% | 25.97 | 26.76 | 25.02 |
Cerevel Therapeutics Holdings, Inc. Events
Time (UTC) | Country | Event |
---|---|---|
No events scheduled |
- 年度
- 每季度
2019 | 2020 | 2021 | |
---|---|---|---|
总收入 | 0 | 0 | 0 |
营业收入 | 0 | -149.116 | -220.098 |
摊薄调整 | 0 | ||
摊薄净收入 | 0 | -148.271 | -225.334 |
总营业费用 | 149.116 | 220.098 | |
销售/一般/行政费用,总计 | 45.813 | 58.243 | |
研究与开发 | 103.303 | 161.855 | |
利息收入(费用),非经营净值 | 0.224 | 0.157 | |
其他,净值 | -3.274 | -5.393 | |
税前净收入 | -152.166 | -225.334 | |
税后净收入 | -152.142 | -225.334 | |
未计算非常项目前的净收益 | -152.142 | -225.334 | |
净收入 | -152.142 | -225.334 | |
Total Adjustments to Net Income | 3.871 | 0 | |
普通股股东可获收益 (不含非经常性项目) | -148.271 | -225.334 | |
普通股股东可获收益 (含非經常性項目) | -148.271 | -225.334 | |
摊薄后加权平均股 | 73.6433 | 136.577 | |
扣除特别项目的每股摊薄盈利 | -2.01337 | -1.64987 | |
每股正常摊薄盈利 | -2.01337 | -1.64987 |
Q1 2021 | Q2 2021 | Q3 2021 | Q4 2021 | Q1 2022 | |
---|---|---|---|---|---|
总收入 | 0 | 0 | 0 | 0 | 0 |
总营业费用 | 50.571 | 50.51 | 54.527 | 64.49 | 72.53 |
销售/一般/行政费用,总计 | 14.01 | 13.216 | 14.368 | 16.649 | 17.507 |
研究与开发 | 36.561 | 37.294 | 40.159 | 47.841 | 55.023 |
营业收入 | -50.571 | -50.51 | -54.527 | -64.49 | -72.53 |
利息收入(费用),非经营净值 | 0.015 | 0.01 | 0.013 | 0.119 | 0.295 |
其他,净值 | -0.425 | -2.739 | -7.545 | 5.316 | 3.941 |
税前净收入 | -50.981 | -53.239 | -62.059 | -59.055 | -68.294 |
税后净收入 | -50.981 | -53.239 | -62.059 | -59.055 | -68.294 |
未计算非常项目前的净收益 | -50.981 | -53.239 | -62.059 | -59.055 | -68.294 |
净收入 | -50.981 | -53.239 | -62.059 | -59.055 | -68.294 |
普通股股东可获收益 (不含非经常性项目) | -50.981 | -53.239 | -62.059 | -59.055 | -68.294 |
普通股股东可获收益 (含非經常性項目) | -50.981 | -53.239 | -62.059 | -59.055 | -68.294 |
摊薄净收入 | -50.981 | -53.239 | -62.059 | -59.055 | -68.294 |
摊薄后加权平均股 | 127.226 | 127.482 | 144.022 | 147.392 | 147.985 |
扣除特别项目的每股摊薄盈利 | -0.40071 | -0.41762 | -0.4309 | -0.40067 | -0.46149 |
Dividends per Share - Common Stock Primary Issue | 0 | 0 | 0 | 0 | |
每股正常摊薄盈利 | -0.40071 | -0.41762 | -0.4309 | -0.40067 | -0.46149 |
- 年度
- 每季度
2019 | 2020 | 2021 | |
---|---|---|---|
流动资产总额 | 390.56 | 578.017 | |
现金和短期投资 | 383.623 | 565.688 | |
现金等价物 | 383.623 | 193.018 | |
Prepaid Expenses | 6.777 | 11.6 | |
Other Current Assets, Total | 0.16 | 0.729 | |
Total Assets | 445.273 | 688.919 | |
Property/Plant/Equipment, Total - Net | 48.624 | 51.7 | |
Property/Plant/Equipment, Total - Gross | 48.706 | 54.266 | |
Accumulated Depreciation, Total | -0.082 | -2.566 | |
Other Long Term Assets, Total | 6.089 | 6.933 | |
Total Current Liabilities | 29.548 | 42.538 | |
Accounts Payable | 4.993 | 11.298 | |
Accrued Expenses | 24.282 | 30.865 | |
Notes Payable/Short Term Debt | 0 | 0 | |
Other Current Liabilities, Total | 0.273 | 0.375 | |
Total Liabilities | 60.753 | 110.19 | |
Total Long Term Debt | 0 | 33.54 | |
Other Liabilities, Total | 31.205 | 34.112 | |
Total Equity | 384.52 | 578.729 | |
Common Stock | 0.013 | 0.015 | |
Additional Paid-In Capital | 775.417 | 1195.94 | |
Retained Earnings (Accumulated Deficit) | -390.91 | -616.244 | |
Total Liabilities & Shareholders’ Equity | 445.273 | 688.919 | |
Total Common Shares Outstanding | 127.124 | 147.72 | |
短期投资 | 372.67 | ||
Long Term Investments | 52.269 | ||
Long Term Debt | 33.54 | ||
Other Equity, Total | -0.986 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
流动资产总额 | 349.811 | 331.782 | 675.029 | 578.017 | 553.55 |
现金和短期投资 | 343.287 | 327.06 | 669.676 | 565.688 | 542.944 |
现金等价物 | 343.287 | 327.06 | 669.676 | 193.018 | 91.764 |
Prepaid Expenses | 6.362 | 4.597 | 5.257 | 11.6 | 10.004 |
Other Current Assets, Total | 0.162 | 0.125 | 0.096 | 0.729 | 0.602 |
Total Assets | 408.104 | 391.004 | 733.48 | 688.919 | 618.552 |
Property/Plant/Equipment, Total - Net | 51.784 | 51.92 | 51.98 | 51.7 | 52.663 |
Property/Plant/Equipment, Total - Gross | 51.876 | 52.552 | 53.526 | 54.266 | 56.299 |
Accumulated Depreciation, Total | -0.092 | -0.632 | -1.546 | -2.566 | -3.636 |
Other Long Term Assets, Total | 6.509 | 7.302 | 6.471 | 6.933 | 4.411 |
Total Current Liabilities | 34.151 | 29.257 | 30.8 | 42.538 | 35.318 |
Accounts Payable | 7.755 | 4.986 | 5.445 | 11.298 | 8.183 |
Accrued Expenses | 26.241 | 23.939 | 24.928 | 30.865 | 26.442 |
Notes Payable/Short Term Debt | 0 | 0 | 0 | 0 | 0 |
Other Current Liabilities, Total | 0.155 | 0.332 | 0.427 | 0.375 | 0.693 |
Total Liabilities | 68.068 | 97.117 | 104.4 | 110.19 | 97.053 |
Total Long Term Debt | 0 | 32.242 | 38.612 | 33.54 | 28.324 |
Other Liabilities, Total | 33.917 | 35.618 | 34.988 | 34.112 | 33.411 |
Total Equity | 340.036 | 293.887 | 629.08 | 578.729 | 521.499 |
Common Stock | 0.013 | 0.013 | 0.015 | 0.015 | 0.015 |
Additional Paid-In Capital | 781.914 | 789.004 | 1186.79 | 1195.94 | 1207.36 |
Retained Earnings (Accumulated Deficit) | -441.891 | -495.13 | -557.189 | -616.244 | -684.538 |
Total Liabilities & Shareholders’ Equity | 408.104 | 391.004 | 733.48 | 688.919 | 618.552 |
Total Common Shares Outstanding | 127.325 | 127.585 | 147.136 | 147.72 | 148.183 |
Long Term Debt | 32.242 | 38.612 | 33.54 | 28.324 | |
Other Equity, Total | -0.533 | -0.986 | -1.334 | ||
短期投资 | 372.67 | 451.18 | |||
Long Term Investments | 52.269 | 7.928 |
- 年度
- 每季度
2019 | 2020 | 2021 | |
---|---|---|---|
净收入/起跑线 | -152.142 | -225.334 | |
经营活动产生的现金 | -117.802 | -178.546 | |
经营活动产生的现金 | 0.397 | 2.731 | |
非现金物品 | 16.236 | 28.516 | |
营运资金的变化 | 17.707 | 15.541 | |
投资活动产生的现金 | -18.892 | -435.661 | |
资本支出 | -18.892 | -10.503 | |
融资活动产生的现金 | 440.835 | 423.602 | |
融资现金流项目 | 440.835 | -0.355 | |
现金净变化 | 304.141 | -190.605 | |
其他投资现金流量项目,总计 | -425.158 | ||
股票的发行(报废),净额 | 392.707 | ||
债务的发行(退还),净额 | 31.25 |
Mar 2021 | Jun 2021 | Sep 2021 | Dec 2021 | Mar 2022 | |
---|---|---|---|---|---|
Net income/Starting Line | -50.981 | -104.22 | -166.279 | -225.334 | -68.294 |
Cash From Operating Activities | -36.418 | -82.026 | -125.802 | -178.546 | -67.648 |
Cash From Operating Activities | 0.063 | 0.664 | 1.644 | 2.731 | 1.118 |
Non-Cash Items | 6.377 | 14.084 | 27.551 | 28.516 | 4.935 |
Changes in Working Capital | 8.123 | 7.446 | 11.282 | 15.541 | -5.407 |
Cash From Investing Activities | -4.66 | -8.243 | -9.431 | -435.661 | -38.542 |
Capital Expenditures | -4.66 | -8.243 | -9.431 | -10.503 | -2.197 |
Cash From Financing Activities | 0.742 | 33.706 | 421.286 | 423.602 | 2.603 |
Issuance (Retirement) of Stock, Net | 0.742 | 2.571 | 390.036 | 392.707 | 2.854 |
Net Change in Cash | -40.336 | -56.563 | 286.053 | -190.605 | -103.587 |
Financing Cash Flow Items | -0.115 | 0 | -0.355 | -0.251 | |
Issuance (Retirement) of Debt, Net | 31.25 | 31.25 | 31.25 | ||
Other Investing Cash Flow Items, Total | -425.158 | -36.345 |
投资者名称 | 投资者类型 | 流通股百分比 | 持有股份 | 股份变动 | 持有日期 | 换手率 |
---|---|---|---|---|---|---|
Bain Capital Private Equity, LP | Private Equity | 38.7867 | 60632356 | 0 | 2022-09-30 | LOW |
Pfizer Inc | Corporation | 17.4954 | 27349211 | 0 | 2022-08-16 | MED |
Fidelity Management & Research Company LLC | Investment Advisor | 14.5762 | 22785810 | 1072862 | 2022-09-30 | LOW |
Perceptive Advisors LLC | Private Equity | 4.1656 | 6511727 | 0 | 2022-09-30 | LOW |
The Vanguard Group, Inc. | Investment Advisor/Hedge Fund | 3.7506 | 5863050 | 861581 | 2022-09-30 | LOW |
T. Rowe Price Associates, Inc. | Investment Advisor | 3.0327 | 4740842 | -1555066 | 2022-09-30 | LOW |
Federated Hermes Global Investment Management Corp. | Investment Advisor/Hedge Fund | 2.1195 | 3313333 | 200000 | 2022-09-30 | LOW |
BlackRock Institutional Trust Company, N.A. | Investment Advisor | 2.025 | 3165508 | 43098 | 2022-09-30 | LOW |
State Street Global Advisors (US) | Investment Advisor/Hedge Fund | 1.7395 | 2719272 | 304798 | 2022-09-30 | LOW |
Rock Springs Capital Management LP | Hedge Fund | 1.5987 | 2499148 | 732007 | 2022-09-30 | LOW |
T. Rowe Price Investment Management, Inc. | Investment Advisor | 1.2803 | 2001437 | 2001437 | 2022-09-30 | HIGH |
Invus Public Equities Advisors, LLC | Investment Advisor | 1.2794 | 2000000 | 500000 | 2022-09-30 | LOW |
Janus Henderson Investors | Investment Advisor/Hedge Fund | 0.8847 | 1382960 | 1369554 | 2022-09-30 | LOW |
Geode Capital Management, L.L.C. | Investment Advisor/Hedge Fund | 0.7256 | 1134261 | 81971 | 2022-09-30 | LOW |
Lord, Abbett & Co. LLC | Investment Advisor | 0.6947 | 1085956 | 82992 | 2022-09-30 | MED |
Point72 Asset Management, L.P. | Hedge Fund | 0.6936 | 1084240 | 881940 | 2022-09-30 | HIGH |
Alkeon Capital Management LLC | Investment Advisor/Hedge Fund | 0.6291 | 983408 | -35667 | 2022-09-30 | LOW |
Hood River Capital Management LLC | Investment Advisor | 0.5735 | 896572 | 473322 | 2022-09-30 | MED |
BlackRock Financial Management, Inc. | Investment Advisor/Hedge Fund | 0.4714 | 736972 | 11220 | 2022-09-30 | LOW |
Novalis LifeSciences LLC | Private Equity | 0.4052 | 633350 | 0 | 2022-03-31 |
为什么选择 Capital.com?让我们的数字来说话。
Capital.com Group交易計算器
Calculate your hypothetical P&L if you had opened a CFD trade on a certain date (select a date) and closed on a different date (select a date).
貿易佣金
0
- 1:1
- 2:1
- 5:1
- 10:1
- 20:1
杠杆
20:1
- 20
- 100
- 500
- 1000
- 10000
投資
交易規模(槓桿 x 投資):
開倉
平倉
做空 做多
Cerevel Therapeutics Holdings, Inc. Company profile
关于 Cerevel Therapeutics Holdings Inc.
Cerevel Therapeutics Holdings, Inc.是一家处于临床阶段的生物制药公司。 公司将对疾病相关生物学和大脑神经回路的理解与化学和中枢神经系统(CNS)、受体药理学相结合,发现和设计新疗法。 公司正在从事神经科学疾病的新疗法的开发,包括精神分裂症、癫痫和帕金森病。 公司的候选产品包括CVL-231、Darigabat、Tavapadon、CVL-871和CVL-936。 公司的候选产品CVL-231用于治疗精神分裂症。 其Darigabat用于治疗癫痫和焦虑症。 其Tavapadon是一种多巴胺D1/D5部分激动剂,用于治疗早期和晚期帕金森病。 其候选产品CVL-871用于治疗痴呆症相关的冷漠症。 其CVL-936用于治疗物质使用障碍(SUD)。
Industry: | Bio Therapeutic Drugs |
222 Jacobs Street
Suite 200
CAMBRIDGE
MASSACHUSETTS 02141
US
收入报表
- Annual
- Quarterly
人们也观看
还在找一位您可以信任的经纪商吗?
加入成为全球500,000万多名交易者的一份子,选择利用Capital.com进行交易吧。